++ Winner Announcement, 2 September 2026: Register Now ++ Upcoming Awards: Discover how to enter here

++ Winner Announcement, 2 September 2026: Register Now ++ Upcoming Awards: Discover how to enter here

nominated 2024

IBD Note

Takeda Pharmaceutical Company Limited

Service Health

IBD Note is a self-management app for patients with inflammatory bowel disease (IBD), planned and developed by Takeda Pharmaceutical Company, and supervised by Dr. Kaoru Yokoyama, Department of Gastroenterology, Kitasato University School of Medicine.

The information presented here is from the time of the award and may differ from the current situation.

Year

2024

Category

Product

Country

Japan

Design Studio / Department

Japan Pharma Business Unit